Abstract:Objective To explore the clinical significance of multidrug resistance (MDR1) expression and its correlation with P 53 in esophageal carcinoma.Methods The expression of MDR1 by in situ hybridization in 57 esophageal carcinomas and the expression of P 53 by immunohistochemistry in 44 of 57 esophageal carcinomas were analyzed,and then evaluated their relationship with clinicopathological factors and their correlation.Results The positive expression rate of MDR1mRNA was 35%in 57 esophageal carcinomas.Eight positive expression cases (29%) were found in 28 cases without lymph node metastasis,and 12 positive expression cases (41%) were found in 29 cases with lymph node metastasis;Eight positive expression cases (27%) were found in 30 clinical II stage cases,and 12 positive expression cases (44%) were found in 27 clinical III-IV stage cases.No significant correlation was found among MDR1mRNA expression and tumor size,position,differentiation degree and infiltration degree.The positive expression rate of mutation P 53 was 73%in 44 esophageal carcinomas.Five positive expression cases (45%) were found in 11 cases that tumor cells invaded to muscle,and 27 positive expression cases (41%) were found in 33 cases that tumor cells invaded to serous membrane.Significant difference between them was found(P 0.01).No significant correlation was found among mutation P 53 expression and tumor size,position,differentiation degree,lymph node metastasis state and clinical stage.Ten MDR1mRNA positive expression cases were found in 32 P 53 positive expression cases,no significant correlation between them(P 0.01).Conclusion Over expressions of MDR1mRNA and mutation P 53 were significantly associated with esophageal carcinoma progression.The expression of MDR1mRNA might not be regulated by mutation P 53.

Expressions of P53 and Nm23 Proteins in Oral Squamous Cell Carcinoma

Immunohistochemical Analysis of P57(kip2), P53 and Hsp60 Expressions in Premalignant and Malignant Oral Tissues

The Study of C-erbB-2 and Nm23 Protein in Oral Squamous Cell Carcinoma

Expression of MDR1mRNA detected and its correlation with p53 in esophageal carcinoma by in situ hybridization

Expressions of p53 and hMSH2 in colon carcinoma

[Expression of Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor Receptor-3 and Nm23-H1 in Oral Squamous Cell Carcinoma].

Expression of Nm23-H_1 Protein in Human Colorectal Carcinoma

Expressions of Nucleoside Diphosphate Kinase (nm23) in Tumor Tissues Are Related with Metastasis and Length of Survival of Patients with Hepatocellular Carcinoma

Relation of NM23-H1 and CD44v6 Expression to Patient's Prognosis in the Non-Small Cell Lung Cancer Without Lymph Node Metastasis

[Expression and correlation of HPV16E6 and tumor suppressor gene p53 in oral squamous cell carcinoma]

EXPRESSION OF MATRIX METALLOPROTEINASE-2 IN LUNG SQUAMOUS CELL CARCINOMA

The Expressions and Significances of Ki67,p53 and P-glycoprotein in Lung Squamous Cell Carcinomas and Adenocarcinomas

[Expressions of PDCD5 and P53 in Oral Leukoplakia and Oral Squamous Cell Carcinoma].

Relationship Between Mrna Expression of Metastasis Suppressor Gene Nm23 and Clinicopathological Features and Prognosis of Non Small Cell Lung Carcinoma

Relationship between nm23H1 genetic instability and clinical pathological characteristics in Chinese digestive system cancer patients

Prognostic Value and Clinicopathologic Significance of Nm23 in Various Cancers: A Systematic Review and Meta-Analysis

PCNA and P53 Expression in Oral Squamous Cell Carcinomas Before and after Locoregional Immunotherapy of Interleukin 2(IL-2) in Combination with Chemotherapy

Expressions of P-selectin and nm23 protein in lung cancer and their correlation with tumor metastasis

Analysis of CyclinD1,p27 and PTEN Proteins Expression in Oral Squamous Cell Carcinoma

Expression and significance of Her-2,P53 and Ki-67 in colorectal cancer

[The Expression of P53, Cyclin D1 and PCNA in Non-Small Cell Lung Cancer].